Why is Trident Texofab falling/rising?

As of 17-Nov, Trident Texofab Ltd's stock price is currently at Rs 337.50, reflecting an increase of Rs 9.5, or 2.9%. The stock has shown strong performance today, outperforming its sector by 2.49% and marking its fourth consecutive day of gains, with a total increase of 6.67% over this period. It opened with a significant gain of 8.08% and reached an intraday high of Rs 354.5. However, despite these positive movements, there is a notable decline in investor participation, with delivery volume dropping by 78.53% compared to the 5-day average. The stock has performed well over the long term, with a year-to-date increase of 100.65% and a remarkable 233.66% rise over the past year, although it has seen a decline of 6.69% over the past month.
In the broader market context, Trident Texofab's short-term performance has significantly outpaced the benchmark Sensex, which has only increased by 1.69% over the past week. This indicates that while the stock is experiencing a positive trend in the short term, it has faced challenges in the month prior. The stock's strong long-term returns, particularly over the past three and five years, suggest a solid growth trajectory, but the recent drop in delivery volume may raise concerns about sustained investor interest. Overall, the combination of recent gains and long-term performance contrasts with the declining participation, highlighting a complex market sentiment surrounding the stock.